Solventum EV/EBIT SOLV
Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2025.
- Today, Oct 23, 2026
- 8.4×
- Peer median
- 19.5×
Solventum's EV/EBIT is 8.4× as of Oct 23, 2026.
The median for 10 medical instruments and supplies stocks of a similar size is 19.5×.
EV/EBIT over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 8.4× | 6.7× | 9.1× |
| 2025 | 7.6× | 6.9× | 23.1× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Solventum's size, closest first, today.
| Company | EV/EBIT |
|---|---|
| SOLVSolventum | 8.4× |
| PENPenumbra | 65.8× |
| COOCooper Companies | 17.2× |
| ALGNAlign Technology | 16.2× |
| GMEDGlobus Medical | 16.3× |
| PODDInsulet | 20.4× |
| WSTWest Pharmaceutical Services | 39.5× |
| MSAMSA Safety | 18.0× |
| RMDResMed | 18.7× |
| MMSIMerit Medical Systems | 28.6× |
| HAEHaemonetics | 26.8× |
| Peer median | 19.5× |
Where Solventum ranks
What the EV/EBIT tells you
What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.
Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.
More on Solventum
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.